Toll-like receptor 9 polymorphisms influence mother-to-child transmission of human immunodeficiency virus type 1

Journal of Translational Medicine

Volumn 8, Issue , 2010, Pages

  Ricci, Elisabetta ^a   Malacrida, Sandro ^a   Zanchetta, Marisa ^b   Mosconi, Ilaria ^a   Montagna, Marco ^b   Giaquinto, Carlo ^a   De Rossi, Anita ^a,b  

^a UNIVERSITY OF PADOVA   (Italy)

^b VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

TOLL LIKE RECEPTOR 9; TLR9 PROTEIN, HUMAN;

ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFANT; INFECTION RISK; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PERINATAL INFECTION; PLACENTAL TRANSFER; PRESCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; VIRUS TRANSMISSION; DISEASE TRANSMISSION; GENETIC PREDISPOSITION; GENETICS; HAPLOTYPE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PHYSIOLOGY; VERTICAL TRANSMISSION;

FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HIV INFECTIONS; HIV-1; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; POLYMORPHISM, SINGLE NUCLEOTIDE; TOLL-LIKE RECEPTOR 9;

EID: 77952480846     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-8-49     Document Type: Article

References (19)

1. The European Collaborative Study: Maternal viral load and vertical transmission of HIV-1: an important factor but not the only one. AIDS 1999, 13:1377-1385. 10.1097/00002030-199907300-00016, 10449292, The European Collaborative Study:.
2. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006, 124:783-801. 10.1016/j.cell.2006.02.015, 16497588.
3. Uematsu S, Akira S. Toll-like receptors and innate immunity. J Mol Med 2006, 84:712-725. 10.1007/s00109-006-0084-y, 16924467.
4. Ferwerda B, Kibiki GS, Netea MG, Dolmans WM, van der Ven AJ. The toll-like receptor 4 Asp299Gly variant and tuberculosis susceptibility in HIV-infected patients in Tanzania. AIDS 2007, 21:1375-1377. 10.1097/QAD.0b013e32814e6b2d, 17545720.
5. Oh DY, Taube S, Hamouda O, Kücherer C, Poggensee G, Jessen H, Eckert JK, Neumann K, Storek A, Pouliot M, Borgeat P, Oh N, Schreier E, Pruss A, Hattermann K, Schumann RR. A functional toll-like receptor 8 variant is associated with HIV disease restriction. J Infect Dis 2008, 198:701-709. 10.1086/590431, 18605904.
6. Bochud PY, Hersberger M, Taffé P, Bochud M, Stein CM, Rodrigues SD, Calandra T, Francioli P, Telenti A, Speck RF, Aderem A, . Swiss HIV Cohort Study Polymorphisms in Toll-like receptor 9 influence the clinical course of HIV-1 infection. AIDS 2007, 21:441-446. 10.1097/QAD.0b013e328012b8ac, 17301562, Swiss HIV Cohort Study.
7. Soriano-Sarabia N, Vallejo A, Ramírez-Lorca R, Rodríguez Mdel M, Salinas A, Pulido I, Sáez ME, Leal M. Influence of the Toll-like receptor 9 1635A/G polymorphism on CD4 count, HIV viral load, and clinical progression. J Acquir Immune Defic Syndr 2008, 49:128-135. 10.1097/QAI.0b013e318184fb41, 18769358.
8. Pine SO, McElrath MJ, Bochud PY. Polymorphisms in toll-like receptor 4 and toll-like receptor 9 influence viral load in a seroincident cohort of HIV-1-infected individuals. AIDS 2009, 27:2387-95.
9. Barton GM, Kagan JC, Medzhitov R. Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA. Nat Immunol 2006, 7:49-56. 10.1038/ni1280, 16341217.
10. De Rossi A, Ades AE, Mammano F, Del Mistro A, Amadori A, Giaquinto C, Chieco-Bianchi L. Antigen detection, virus culture, polymerase chain reaction, and in vitro antibody production in the diagnosis of vertically transmitted HIV-1 infection. AIDS 1991, 5:15-20. 10.1097/00002030-199101000-00002, 2059357.
11. Ricci E, Malacrida S, Zanchetta M, Montagna M, Giaquinto C, De Rossi A. Role of β-Defensin-1 polymorphisms in mother-to-child transmission of Human Immunodeficiency Virus Type 1. J Acquir Immune Defic Syndr 2009, 51:13-19. 10.1097/QAI.0b013e31819df249, 19390326.
12. Solé X, Guinó E, Valls J, Iniesta R, Moreno. SNPStats: a web tool for the analysis of association studies. Bioinformatics 2006, 22:1928-1929. 10.1093/bioinformatics/btl268, 16720584.
13. Jamieson DJ, Clark J, Kourtis AP, Taylor AW, Lampe MA, Fowler MG, Mofenson LM. Recommendations for human immunodeficiency virus screening, prophylaxis, and treatment for pregnant women in the United States. Am J Obstet Gynecol 2007, 197:S26-32. 10.1016/j.ajog.2007.03.087, 17825647.
14. Bowie AG, Haga IR. The role of Toll-like receptors in the host response to viruses. Mol Immunol 2005, 42:859-867. 10.1016/j.molimm.2004.11.007, 15829275.
15. Müller T, Hamm S, Bauer S. TLR9-mediated recognition of DNA. Handb Exp Pharmacol 2008, 183:51-70. full_text, 18071654.
16. Carpenter EL, Mick R, Rüter J, Vonderheide RH. Activation of human B cells by the agonist CD40 antibody CP-870,893 and augmentation with simultaneous toll-like receptor 9 stimulation. J Transl Med 2009, 7:93. 10.1186/1479-5876-7-93, 2777861, 19906293.
17. Tao K, Fujii M, Tsukumo S, Maekawa Y, Kishihara K, Kimoto Y, Horiuchi T, Hisaeda H, Akira S, Kagami S, Yasutomo K. Genetic variations of Toll-like receptor 9 predispose to systemic lupus erythematosus in Japanese population. Ann Rheum Dis 2007, 66:905-909. 10.1136/ard.2006.065961, 17344245.
18. Leoratti FM, Farias L, Alves FP. Variants in the toll-like receptor signaling pathway and clinical outcomes of malaria. J Infect Dis 2008, 198:772-780. 10.1086/590440, 18662133.
19. Mandl JN, Barry AP, Vanderford TH, Kozyr N, Chavan R, Klucking S, Barrat FJ, Coffman RL, Staprans SI, Feinberg MB. Divergent TLR7 and TLR9 signaling and type I interferon production distinguish pathogenic and nonpathogenic AIDS virus infections. Nat Med 2008, 14:1077-1087. 10.1038/nm.1871, 18806803.